Khalid M. Kamal, Ph.D.
Assistant Professor
Division of Clinical, Social & Administrative Sciences

314 Bayer
T 412.396.1926
E kamalk@duq.edu

Bachelor of Pharmacy (B. Pharm), University of Bombay, India
M.S. (Pharmacology), University of Bombay, India
Ph.D. (Pharmacy Administration), West Virginia University

• Economic evaluations of treatments used in musculoskeletal disorders and COPD
• Measuring patient-reported outcomes in chronic conditions

• Pharmacoeconomic Evaluations (GPSC 590) - 3 Crs. (Spring; 100%)
• Patient-Reported Health Outcomes (GPSC 591) - 3 Crs. (Fall; 100%)
• Research Methods in Pharmacy Administration (GPSC 589) - 3 Crs. (Fall; Team Taught - 40%; Course master)

• The American Healthcare System (PHBA 410) - 2 Crs. (Spring; Team Taught - 30%; Course master)
• Pharmacy Practice V (PHPR 447) - 3 Crs. (Fall; Team Taught - 34%)
• Drug Literature Evaluation (PHPR 448-71) - 2 Crs. (Fall; Team Taught - 30%)

Skomo M, Kamal KM, Berdine H. A required course in the development, implementation, and evaluation of clinical pharmacy services. American Journal of Pharmaceutical Education. 2008; 72(5): Article 109.

Kamal KM, Sakamaki A, Bricker JD, Kawasaki K. An elective course in pharmacoeconomics for pharmacy students in Japan - A transcultural experience. Submitted - American Journal of Pharmaceutical Education.

Surratt CK, Kamal KM, Wildfong PD. Research Funding Expectations as a Function of Faculty Teaching/Administrative Workload. Submitted - Currents in Pharmacy Teaching and Learning.

Kamal KM, Sakamaki A, Shirakawa S, Kawasaki K, Akaho E, Bricker JD. Need for pharmacoeconomics in the Japanese healthcare system: Experiences from teaching an elective course for pharmacy students in Kobe Gakuin University, Kobe. Accepted - The Annual Meeting of Japan Pharmacist Association (JPA).

Kamal KM, Sakamaki A, Bricker JD, Kawasaki K. An elective course in pharmacoeconomics for pharmacy students in Japan - A transcultural experience. (Accepted - The Annual Meeting of American Association of Colleges of Pharmacy (AACP), Boston, July 2009.

Giannetti V, Lasilla H, O’Neil C, Kamal KM. Integration of public health into an American Healthcare Systems course. The annual meeting of the American Association of Colleges of Pharmacy (AACP), Chicago, July 2008.

Skomo M, Kamal KM, Berdine H. Integration of CAPE Outcomes into a pharmacy practice course through application of business plan models. The annual meeting of American Association of Colleges of Pharmacy (AACP), Orlando, July 2007.

Yoder JL, Kamal KM. A Systematic Review of Economic Analyses Studying Rituximab in R-CHOP Therapy in Patients with Non-Hodgkin Lymphoma. The Open Cancer Immunology Journal, 2009, 2, 00-00 (Accepted)

Kamal KM, Desselle S, Rane P, Parekh R, Zacker C. Content Analysis of FDA Warning Letters to Manufacturers of Pharmaceuticals and Biologics. Drug Information Journal. 2009;43(4):385-393.

Khanna R, Scott VG, Kavookjian J, Kamal KM, Miller LA, Neal WA. Using the Theory of Reasoned Action to Determine Physicians' Intention to Measure Body Mass Index in Children and Adolescents. Research in Social and Administrative Pharmacy. 2009;5(2): 170-81.

Kamal KM, Madhavan SS, Hornsby JA, Miller LA, Scott V, Kavookjian J. US rheumatologists’ prescribing practices for anti-TNF agents. Published as an abstract in the 'Research Highlights' section of Nature Clinical Practice Rheumatology 2007;3(4):196-197.

Kamal KM. Treating Crohn’s Disease in the 21st Century: An evidence-based review of the management of refractory disease. First Report® March 2007. Invited submission for Continuing Medical Education sponsored by University of Cincinnati and Princeton Media Associates.

Kamal KM, Madhavan SS, Hornsby JA, Miller LA, Scott V, Kavookjian J. Use of tumor necrosis factor inhibitors in rheumatoid arthritis: A national survey of practicing United States rheumatologists. Joint Bone Spine, 2006;73 (6):718-724. Also, published in Revue du Rhumatisme, 2006; 73(12):1387-94 (French).

Kamal KM, Miller LA, Kavookjian J, Madhavan SS. Alternative decision analysis modeling in the economic evaluation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 2006:36(1):50-60.

Tompkins NO, Kamal KM, Chapman D. West Virginia Health Education Assessment Project. Journal of School Health 2005;75(6):193-198.

Orsini L, Limpa-Amara S, Crown WH, Stanford RH, Kamal KM. Asthma hospitalization risk and costs for patients treated with fluticasone propionate versus montelukast. Annals of Asthma, Allergy and Immunology 2004;92:523-529.

Dino GA, Kamal KM, Kalsekar ID, Fernandes AW, Horn KA. Stages of change and smoking cessation outcomes in adolescents. Addictive Behavior 2004;29(5):935-40.

Kamal KM, Madhavan SS, Maine LL. Pharmacy and immunization services: Pharmacists’ participation and impact. Journal of American Pharmaceutical Association 2003;43(4):470-82.

Kamal KM, Madhavan SS, Amonkar MM. Determinants of adult influenza and pneumonia immunization rates. Journal of American Pharmaceutical Association 2003;43(3):403-11.

Kamal KM, Madhavan SS, Maine LL. Pharmacists and immunization services: Impact of American Pharmaceutical Association’s (APhA) Immunization Training Certification Program. American Journal of Pharmaceutical Education 2003;67(4):article 124.

Nair AM, Mungantiwar AA, Kamal KM, Saraf MN. Modulation of invitro anaphylaxis by furosemide. Indian Journal of Pharmacology 1997;29:182-186.

Nair AM, Mungantiwar AA, Kamal KM, Saraf MN. Antiallergic potential of furosemide. Indian Journal of Experimental Biology 1997;35:466-469.

Sartore M, Kamal KM. Questions of costs & thresholds in cost-effectiveness analysis.  Accepted for publication in Alimentary Pharmacology and Therapeutics.

Kamal KM, Miller LA. Psychosocial factors and asthma.  American Journal of Respiratory and Critical Care Medicine 2004;169(11):1253-54.

Parekh R, Rane P, Kamal KM. Enhancing pharmacist-physician communication: A step towards reducing medication errors. Bulletin of the Allegheny County Medical Society 2007; :508-09,511-12 [In print]. 

Kamal KM. Cost-effectiveness analysis of tumor necrosis factor inhibitors in rheumatoid arthritis. Bulletin of the Allegheny County Medical Society 2006; 95(3):126-31. 

Naik S, Kamal KM, Keys P, Mattei T. Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease.

Kamal KM. Introduction to Budget Impact Analysis. WVU Student ISPOR Chapter at West Virginia University School of Pharmacy, April 2009.

Kamal KM. Need for pharmacoeconomics in the Japanese Healthcare System. Visiting Professor, Kobe-Gakuin University School of Pharmacy, Kobe, Japan. Invited presentation at Kobe City Medical Center General Hospital, October 2008.

• Rane PB, Kamal KM, Keys P, Giannetti V. Hospital resource utilization in patients with chronic obstructive pulmonary disease: An analysis of the 2005 National Inpatient Sample data. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Orlando, May 2009. Abstract published in Value in Health 2009;12(2):A127.
• Parekh R, Kamal KM, Mihalyo M, Runyon A. Medication costs and utilization in a Hospice care. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Orlando, May 2009. Abstract published in Value in Health 2009; 12(2):A82.
• Mandock k, Tomko J, Giannetti V, Kamal KM. Non-adherence to pharmacotherapy as a potential risk factor for relapse to substance use disorder in dual diagnosis patients. The Annual Meeting of the College of Psychiatric and Neurologic Pharmacists, Jacksonville, April 2009.
• Kamal KM, Rane P, Parekh R, Desselle S, Zacker C. Analysis of FDA warning letters and notices to manufacturers of pharmaceuticals concerning health outcomes-related promotional claims violations. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Toronto, May 2008. Abstract published in Value in Health 2008;11(3):A53.
• Parekh HH, Kamal KM, Smith MJ, Skomo M. Resource utilization among inpatients with rheumatoid arthritis – An analysis of 2004 Healthcare Cost and Utilization Project data. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Toronto, May 2008. Abstract published in Value in Health 2008;11(3):A262.
• Parekh HH, Kamal KM, Skomo M, Smith MJ. Trends in hospitalizations among inpatients with Rheumatoid Arthritis – An analysis of 2002-2004 Healthcare Cost and Utilization Project data. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Toronto, May 2008. Abstract published in Value in Health 2008;11(3):A262.
• Shah N, Kamal KM. Review of Quality of Life instruments in Migraine. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Toronto, May 2008. Abstract published in Value in Health 2008;11(3):A145.
• Khanna R, Scott VG, Kavookjian J, Kamal KM, Miller LA, Neal WA. Physicians’ intention to measure body mass index in children and adolescents: A theory of Reasoned Action Model. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Toronto, May 2008. Abstract published in Value in Health 2008;11(3):A167.
• Parekh R, Rane P, Kamal KM, Desselle S. Content analysis of FDA warning letters to manufacturers concerning promotional violations. The annual meeting of American Managed Care Pharmacy (AMCP), Boston, October 2007. Abstract published in Journal of Managed Care Pharmacy 2007; 13(8):692.
• Khanna R, Smith MJ, Kamal KM. Utilization of chronic arthritis-related healthcare services by children and adolescents in a Medicaid population. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007;10(3):A121.
• Naik S, Kamal KM, Keys P, Mattei T. Evaluating the cost-effectiveness of tiotropium in the treatment of moderate chronic obstructive pulmonary disease. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007;10(3):A178.
• Naik S, Kamal KM. Measurement of quality of life in restless legs syndrome. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007;10(3):A94.
• Parekh HH, Kamal KM. Economic evaluation of tumor necrosis factor inhibitors in the treatment of ankylosing spondylitis. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007;10(3):A118.
• Rane PB, Kamal KM. A review of health related quality of life instruments used in children and adolescents with epilepsy. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007;10(3):A94.
• Parekh HH, Kamal KM. Tumor Necrosis Factor Inhibitors - A pharmacoeconomic review of its use in Ankylosing Spondylitis. Midwest Social and Administrative Pharmacy Conference, Minneapolis, July 2006. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007;10(3):A120.
• Parekh RH, Kamal KM, Desselle S. Smoking status and pneumonia immunization: Findings from the 2005 Behavioral Risk Factor Surveillance System (BRFSS) data. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007; 10(3):A168.
• Parekh H, Kamal KM. A systematic review of quality of life measures in ankylosing spondylitis. The annual meeting of the American Pharmacists Association (APhA), Atlanta, GA, March 2007. Abstract published in Journal of American Pharmacists Association 2007;47(2):255.
• Kamal KM, Miller LA. A cost-effectiveness analysis of treatment strategies including tumor necrosis factor inhibitors and abatacept for patients with active rheumatoid arthritis. The annual Meeting of the Society for Medical Decision Making, Boston, MA, October 2006.
• Naik S, Kamal KM. Estimating cost-effectiveness of tiotropium for treating chronic obstructive pulmonary disease. Midwest Social and Administrative Pharmacy Conference, Minneapolis, July 2006.
• Tagliavia N, Kamal KM, Desselle S. A comparison of health-related quality of life (HRQoL) of persons with and without arthritis or chronic joint symptoms (CJS). Midwest Social and Administrative Pharmacy Conference, Minneapolis, July 2006. Also presented at the annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Philadelphia, May 2006 Abstract published in Value in Health 2006; 9(3):A29.

Title: Quality improvement in physician process and patient outcomes in diabetes care.
Amount: $5,000
Agency: Duquesne University Presidential Scholarship Award
Role/Date: Principal Investigator, April 1, 2008 to March 30, 2009

Title: Pharmacoeconomic evaluation of tumor necrosis factor inhibitors in the treatment of Ankylosing Spondylitis
Amount: $9,887
Agency: Duquesne University Faculty Development Fund
Role/Date: Principal Investigator, May 1, 2007 to April 30, 2009

Title: Consequences of pharmacy benefits design: An examination of clinical, economic, ethical, and humanistic considerations.
Amount: $22,696.33
Agency: Novartis Pharmaceuticals Corporation
Role/Date: Co-Principal Investigator, December 1, 2006 to June 1, 2007

Title: Content analysis of FDA warning letters to manufacturers of pharmaceuticals and biologics.
Amount: $7,389.37
Agency: Novartis Pharmaceuticals Corporation
Role/Date: Co-Principal Investigator, December 1, 2006 to June 1, 2007

Khanna R, Kamal KM, Smith M. Utilization and costs of drugs and office services among recipients of Medicaid with rheumatoid arthritis with versus without comorbid depression. Association of Rheumatology Health Professionals Graduate Student Award (2006)

Graduate Research Award, School of Pharmacy, WVU (2001-2002)

All India Council of Technical Education Junior Research Fellowship (1994-1996)

Value in Health
Journal of Rheumatology
Clinical Therapeutics
Journal of Managed Care Pharmacy
Research in Social and Administrative Pharmacy
American Journal of Health-System Pharmacy
Expert Review for Medical Devices

International Society for Pharmacoeconomics & Outcomes Research (ISPOR)
Association of Rheumatology Health Professionals (ARHP)
American Association of Colleges of Pharmacy (AACP)
Society for Medical Decision Making (SMDM)
Rho Chi Honor Society
Economic Club of Pittsburgh